by NCCF Staff | Mar 24, 2021 | Canine Cancer Blog
Hemangiosarcoma (HSA) is one of the most aggressive cancers out there with a very low survival rate by the time it is detected in our dogs. Hemangiosarcoma treatments in dogs have previously only extended the life of a dog few months. That’s the reason NCCF has funded...
by Kyle Stevenson | Mar 1, 2021 | Canine Cancer Blog
33% . . . This is the percentage of the US population that claimed to have not eaten peanut butter in 2018. This is also the percentage of the US that is covered by forest. More importantly, this is also the percentage of dogs who will develop cancer at some point in...
by Kristina Evelyn | Jan 20, 2021 | Canine Cancer Blog
Are some dog breeds more prone to cancer than others? The simple answer to this question is “Yes!” However, explaining why some dogs are more likely to get cancer is more complex. It’s true, as commonly thought, that some dog breeds are more prone to cancer than...
by Sara Nice | Feb 3, 2020 | Canine Cancer Blog, Founder Writings
My Super Bowl enjoyment has always been in the commercials, not so much in the game. In the past several years, my interest in the commercials has diminished because there just have not been quite as many good ones as their used to be. As the big game approached, I...
by NCCF Editor | Mar 14, 2019 | Canine Cancer Blog
In October, James P. Allison and Tasuku Honjo won the Nobel Prize in medicine for their groundbreaking cancer research. With the help of mice, they developed six revolutionary cancer treatments that target the immune system. Some patients who received just one round...
Recent Comments